Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00121524Phase 2Completed
Phase 2, randomised, open-label trial of epinephrine in cardiac arrest (SCA) (2 arms). Primary endpoint: Survival to hospital discharge with neurologic outcome. Started Jan 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00121524.